Inhibitory effect of insulin on vasopressin-induced intracellular calcium response is blunted in hyperinsulinemic hypertensive patients: role of membrane fatty acid composition

被引:6
作者
Maekawa, Koichi
Tsujino, Takeshi
Saito, Komei
Kim, Jong Il
Ikeda, Yoshihiro
Emoto, Noriaki
Yokoyama, Mitsuhiro
机构
[1] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc & Resp Med,Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Saito Clin, Takarazuka, Hyogo, Japan
关键词
hypertension; insulin resistance; membrane fatty acid; intracellular calcium; stearic acid;
D O I
10.1007/s00380-005-0889-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Impaired insulin-mediated vasodilation has been implicated in hypertension that is associated with the metabolic syndrome. The aim of this study was to determine whether an abnormality in membrane fatty acid composition was related to a weakening of insulin's inhibitory effect on agonist-stimulated intracellular free calcium elevation. Mild to moderate hypertensive patients (n = 27) and normotensive controls (n = 11) were studied. Hypertensive patients were divided into normoinsulinemic patients (n = 14) and hyperinsulinemic patients (n = 13) according to the area under the curve of plasma insulin concentrations during a 75-g oral glucose tolerance test. Nonstimulated and arginine-vasopressin (AVP) (1 mu mol/l)-stimulated intraplatelet free calcium concentrations (p[Ca2+](i)) were measured with or without insulin (100 mu U/ml) preincubation. Platelet membrane fatty acid composition, intraerythrocyte sodium content, and the ouabain-sensitive sodium efflux rate constant (K (os)) of erythrocytes were also determined. Insulin preincubation reduced AVP-stimulated p[Ca2+](i) elevation in both normotensive controls and hypertensive patients. The inhibitory effect of insulin on AVP-stimulated elevation of p[Ca2+](i) (%Inhibition) was significantly (P < 0.05) blunted in hyperinsulinemic hypertensive patients (9.7% +/- 2.4%) as compared to normoinsulinemic hypertensive patients (17.4% +/- 2.7%) and normotensive controls (16.9% +/- 1.7%). In hypertensive patients, the %Inhibition was correlated negatively with saturated fatty acids (SFA) (r = -0.51, P < 0.05) and systolic blood pressure (r = -0.44, P < 0.05), and correlated positively with membrane polyunsaturated fatty acids (PUFA) (r = 0.53, P < 0.01) and K (os) (r = 0.53, P < 0.005). Multiple regression analysis showed that SFA, PUFA, and K (os) were the significant variables for %Inhibition. These findings indicate that an increase in SFA and a decrease in PUFA may cause insulin insensitivity in cellular calcium and sodium handling in hypertension with hyperinsulinemia.
引用
收藏
页码:205 / 212
页数:8
相关论文
共 50 条
[1]   ABNORMAL CATION COMPOSITION AND TRANSPORT IN ERYTHROCYTES FROM HYPERTENSIVE PATIENTS [J].
ADEROUNMU, AF ;
SALAKO, LA .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1979, 9 (05) :369-375
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]   THE VASODILATOR ACTION OF INSULIN - IMPLICATIONS FOR THE INSULIN HYPOTHESIS OF HYPERTENSION [J].
ANDERSON, EA ;
MARK, AL .
HYPERTENSION, 1993, 21 (02) :136-141
[5]   SKELETAL-MUSCLE BLOOD-FLOW - A POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND BLOOD-PRESSURE [J].
BARON, AD ;
BRECHTELHOOK, G ;
JOHNSON, A ;
HARDIN, D .
HYPERTENSION, 1993, 21 (02) :129-135
[6]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[7]  
BOLLI P, 1984, J CARDIOVASC PHARM, V6, pS996
[8]   THE RELATION BETWEEN INSULIN SENSITIVITY AND THE FATTY-ACID COMPOSITION OF SKELETAL-MUSCLE PHOSPHOLIPIDS [J].
BORKMAN, M ;
STORLIEN, LH ;
PAN, DA ;
JENKINS, AB ;
CHISHOLM, DJ ;
CAMPBELL, LV .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (04) :238-244
[9]   INSULIN RELEASE AND PERIPHERAL SENSITIVITY AT THE ORAL GLUCOSE-TOLERANCE TEST [J].
CEDERHOLM, J ;
WIBELL, L .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1990, 10 (02) :167-175
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497